The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Noninvasive Cancer Diagnostics Technology Market Research Report 2025
Synopsis
Market Analysis and Insights: Global Noninvasive Cancer Diagnostics Technology Market
Noninvasive Cancer Diagnostics Technology is a process for the detection of disease through minimal incisions into the body. Noninvasive cancer diagnostic technologies provide fast and convenient procedures for noninvasive early detection of cancer and provide a valuable aid to the clinician and increased comfort to the patient.Noninvasive Cancer Diagnosis Technologies are used to identify breast, lung, blood, and other cancers.
The global Noninvasive Cancer Diagnostics Technology market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Immunoassays accounting for % of the Noninvasive Cancer Diagnostics Technology global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Medical Device Manufacturing Company segment is altered to an % CAGR throughout this forecast period.
China Noninvasive Cancer Diagnostics Technology market size is valued at US$ million in 2021, while the North America and Europe Noninvasive Cancer Diagnostics Technology are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Noninvasive Cancer Diagnostics Technology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Noninvasive Cancer Diagnostics Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Noninvasive Cancer Diagnostics Technology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Noninvasive Cancer Diagnostics Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Noninvasive Cancer Diagnostics Technology market.
Global Noninvasive Cancer Diagnostics Technology Scope and Market Size
Noninvasive Cancer Diagnostics Technology market is segmented by players, region (country), by Technology and by Application. Players, stakeholders, and other participants in the global Noninvasive Cancer Diagnostics Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Technology and by Application for the period 2017-2028.
Segment by Technology
Immunoassays
Molecular Diagnostics
Clinical Chemistry
Others
Segment by Application
Medical Device Manufacturing Company
Oncology Laboratories
Government and Private Research Institutions
Academic Institutions and Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Precision Therapeutics
Affymetrix Inc.
Gen-Probe Incorporated
AVIVA Biosciences Corporation
A&G Pharmaceutical
BIOVIEW Inc.
Quest Diagnostics Incorporated
Digene Corporation
Laboratory Corporation of America Holdings.
Market Analysis and Insights: Global Noninvasive Cancer Diagnostics Technology Market
Noninvasive Cancer Diagnostics Technology is a process for the detection of disease through minimal incisions into the body. Noninvasive cancer diagnostic technologies provide fast and convenient procedures for noninvasive early detection of cancer and provide a valuable aid to the clinician and increased comfort to the patient.Noninvasive Cancer Diagnosis Technologies are used to identify breast, lung, blood, and other cancers.
The global Noninvasive Cancer Diagnostics Technology market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Immunoassays accounting for % of the Noninvasive Cancer Diagnostics Technology global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Medical Device Manufacturing Company segment is altered to an % CAGR throughout this forecast period.
China Noninvasive Cancer Diagnostics Technology market size is valued at US$ million in 2021, while the North America and Europe Noninvasive Cancer Diagnostics Technology are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Noninvasive Cancer Diagnostics Technology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Noninvasive Cancer Diagnostics Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Noninvasive Cancer Diagnostics Technology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Noninvasive Cancer Diagnostics Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Noninvasive Cancer Diagnostics Technology market.
Global Noninvasive Cancer Diagnostics Technology Scope and Market Size
Noninvasive Cancer Diagnostics Technology market is segmented by players, region (country), by Technology and by Application. Players, stakeholders, and other participants in the global Noninvasive Cancer Diagnostics Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Technology and by Application for the period 2017-2028.
Segment by Technology
Immunoassays
Molecular Diagnostics
Clinical Chemistry
Others
Segment by Application
Medical Device Manufacturing Company
Oncology Laboratories
Government and Private Research Institutions
Academic Institutions and Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Precision Therapeutics
Affymetrix Inc.
Gen-Probe Incorporated
AVIVA Biosciences Corporation
A&G Pharmaceutical
BIOVIEW Inc.
Quest Diagnostics Incorporated
Digene Corporation
Laboratory Corporation of America Holdings.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Technology
1.2.1 Global Noninvasive Cancer Diagnostics Technology Market Size Growth Rate by Technology: 2017 VS 2021 VS 2028
1.2.2 Immunoassays
1.2.3 Molecular Diagnostics
1.2.4 Clinical Chemistry
1.2.5 Others
1.3 Market by Application
1.3.1 Global Noninvasive Cancer Diagnostics Technology Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Medical Device Manufacturing Company
1.3.3 Oncology Laboratories
1.3.4 Government and Private Research Institutions
1.3.5 Academic Institutions and Pharmaceutical Companies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Noninvasive Cancer Diagnostics Technology Market Perspective (2017-2028)
2.2 Noninvasive Cancer Diagnostics Technology Growth Trends by Region
2.2.1 Noninvasive Cancer Diagnostics Technology Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Noninvasive Cancer Diagnostics Technology Historic Market Size by Region (2017-2022)
2.2.3 Noninvasive Cancer Diagnostics Technology Forecasted Market Size by Region (2023-2028)
2.3 Noninvasive Cancer Diagnostics Technology Market Dynamics
2.3.1 Noninvasive Cancer Diagnostics Technology Industry Trends
2.3.2 Noninvasive Cancer Diagnostics Technology Market Drivers
2.3.3 Noninvasive Cancer Diagnostics Technology Market Challenges
2.3.4 Noninvasive Cancer Diagnostics Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Noninvasive Cancer Diagnostics Technology Players by Revenue
3.1.1 Global Top Noninvasive Cancer Diagnostics Technology Players by Revenue (2017-2022)
3.1.2 Global Noninvasive Cancer Diagnostics Technology Revenue Market Share by Players (2017-2022)
3.2 Global Noninvasive Cancer Diagnostics Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Noninvasive Cancer Diagnostics Technology Revenue
3.4 Global Noninvasive Cancer Diagnostics Technology Market Concentration Ratio
3.4.1 Global Noninvasive Cancer Diagnostics Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Noninvasive Cancer Diagnostics Technology Revenue in 2021
3.5 Noninvasive Cancer Diagnostics Technology Key Players Head office and Area Served
3.6 Key Players Noninvasive Cancer Diagnostics Technology Product Solution and Service
3.7 Date of Enter into Noninvasive Cancer Diagnostics Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Noninvasive Cancer Diagnostics Technology Breakdown Data by Technology
4.1 Global Noninvasive Cancer Diagnostics Technology Historic Market Size by Technology (2017-2022)
4.2 Global Noninvasive Cancer Diagnostics Technology Forecasted Market Size by Technology (2023-2028)
5 Noninvasive Cancer Diagnostics Technology Breakdown Data by Application
5.1 Global Noninvasive Cancer Diagnostics Technology Historic Market Size by Application (2017-2022)
5.2 Global Noninvasive Cancer Diagnostics Technology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Noninvasive Cancer Diagnostics Technology Market Size (2017-2028)
6.2 North America Noninvasive Cancer Diagnostics Technology Market Size by Country (2017-2022)
6.3 North America Noninvasive Cancer Diagnostics Technology Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Noninvasive Cancer Diagnostics Technology Market Size (2017-2028)
7.2 Europe Noninvasive Cancer Diagnostics Technology Market Size by Country (2017-2022)
7.3 Europe Noninvasive Cancer Diagnostics Technology Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Noninvasive Cancer Diagnostics Technology Market Size (2017-2028)
8.2 Asia-Pacific Noninvasive Cancer Diagnostics Technology Market Size by Country (2017-2022)
8.3 Asia-Pacific Noninvasive Cancer Diagnostics Technology Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Noninvasive Cancer Diagnostics Technology Market Size (2017-2028)
9.2 Latin America Noninvasive Cancer Diagnostics Technology Market Size by Country (2017-2022)
9.3 Latin America Noninvasive Cancer Diagnostics Technology Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Noninvasive Cancer Diagnostics Technology Market Size (2017-2028)
10.2 Middle East & Africa Noninvasive Cancer Diagnostics Technology Market Size by Country (2017-2022)
10.3 Middle East & Africa Noninvasive Cancer Diagnostics Technology Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Precision Therapeutics
11.1.1 Precision Therapeutics Company Detail
11.1.2 Precision Therapeutics Business Overview
11.1.3 Precision Therapeutics Noninvasive Cancer Diagnostics Technology Introduction
11.1.4 Precision Therapeutics Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
11.1.5 Precision Therapeutics Recent Development
11.2 Affymetrix Inc.
11.2.1 Affymetrix Inc. Company Detail
11.2.2 Affymetrix Inc. Business Overview
11.2.3 Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Introduction
11.2.4 Affymetrix Inc. Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
11.2.5 Affymetrix Inc. Recent Development
11.3 Gen-Probe Incorporated
11.3.1 Gen-Probe Incorporated Company Detail
11.3.2 Gen-Probe Incorporated Business Overview
11.3.3 Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Introduction
11.3.4 Gen-Probe Incorporated Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
11.3.5 Gen-Probe Incorporated Recent Development
11.4 AVIVA Biosciences Corporation
11.4.1 AVIVA Biosciences Corporation Company Detail
11.4.2 AVIVA Biosciences Corporation Business Overview
11.4.3 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Introduction
11.4.4 AVIVA Biosciences Corporation Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
11.4.5 AVIVA Biosciences Corporation Recent Development
11.5 A&G Pharmaceutical
11.5.1 A&G Pharmaceutical Company Detail
11.5.2 A&G Pharmaceutical Business Overview
11.5.3 A&G Pharmaceutical Noninvasive Cancer Diagnostics Technology Introduction
11.5.4 A&G Pharmaceutical Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
11.5.5 A&G Pharmaceutical Recent Development
11.6 BIOVIEW Inc.
11.6.1 BIOVIEW Inc. Company Detail
11.6.2 BIOVIEW Inc. Business Overview
11.6.3 BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Introduction
11.6.4 BIOVIEW Inc. Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
11.6.5 BIOVIEW Inc. Recent Development
11.7 Quest Diagnostics Incorporated
11.7.1 Quest Diagnostics Incorporated Company Detail
11.7.2 Quest Diagnostics Incorporated Business Overview
11.7.3 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Introduction
11.7.4 Quest Diagnostics Incorporated Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
11.7.5 Quest Diagnostics Incorporated Recent Development
11.8 Digene Corporation
11.8.1 Digene Corporation Company Detail
11.8.2 Digene Corporation Business Overview
11.8.3 Digene Corporation Noninvasive Cancer Diagnostics Technology Introduction
11.8.4 Digene Corporation Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
11.8.5 Digene Corporation Recent Development
11.9 Laboratory Corporation of America Holdings.
11.9.1 Laboratory Corporation of America Holdings. Company Detail
11.9.2 Laboratory Corporation of America Holdings. Business Overview
11.9.3 Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Introduction
11.9.4 Laboratory Corporation of America Holdings. Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
11.9.5 Laboratory Corporation of America Holdings. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Noninvasive Cancer Diagnostics Technology Market Size Growth Rate by Technology (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Immunoassays
Table 3. Key Players of Molecular Diagnostics
Table 4. Key Players of Clinical Chemistry
Table 5. Key Players of Others
Table 6. Global Noninvasive Cancer Diagnostics Technology Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Noninvasive Cancer Diagnostics Technology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Noninvasive Cancer Diagnostics Technology Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Noninvasive Cancer Diagnostics Technology Market Share by Region (2017-2022)
Table 10. Global Noninvasive Cancer Diagnostics Technology Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Noninvasive Cancer Diagnostics Technology Market Share by Region (2023-2028)
Table 12. Noninvasive Cancer Diagnostics Technology Market Trends
Table 13. Noninvasive Cancer Diagnostics Technology Market Drivers
Table 14. Noninvasive Cancer Diagnostics Technology Market Challenges
Table 15. Noninvasive Cancer Diagnostics Technology Market Restraints
Table 16. Global Noninvasive Cancer Diagnostics Technology Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Noninvasive Cancer Diagnostics Technology Market Share by Players (2017-2022)
Table 18. Global Top Noninvasive Cancer Diagnostics Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Cancer Diagnostics Technology as of 2021)
Table 19. Ranking of Global Top Noninvasive Cancer Diagnostics Technology Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Noninvasive Cancer Diagnostics Technology Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Noninvasive Cancer Diagnostics Technology Product Solution and Service
Table 23. Date of Enter into Noninvasive Cancer Diagnostics Technology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Noninvasive Cancer Diagnostics Technology Market Size by Technology (2017-2022) & (US$ Million)
Table 26. Global Noninvasive Cancer Diagnostics Technology Revenue Market Share by Technology (2017-2022)
Table 27. Global Noninvasive Cancer Diagnostics Technology Forecasted Market Size by Technology (2023-2028) & (US$ Million)
Table 28. Global Noninvasive Cancer Diagnostics Technology Revenue Market Share by Technology (2023-2028)
Table 29. Global Noninvasive Cancer Diagnostics Technology Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Noninvasive Cancer Diagnostics Technology Revenue Market Share by Application (2017-2022)
Table 31. Global Noninvasive Cancer Diagnostics Technology Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Noninvasive Cancer Diagnostics Technology Revenue Market Share by Application (2023-2028)
Table 33. North America Noninvasive Cancer Diagnostics Technology Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Noninvasive Cancer Diagnostics Technology Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Noninvasive Cancer Diagnostics Technology Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Noninvasive Cancer Diagnostics Technology Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Noninvasive Cancer Diagnostics Technology Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Noninvasive Cancer Diagnostics Technology Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Noninvasive Cancer Diagnostics Technology Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Noninvasive Cancer Diagnostics Technology Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Noninvasive Cancer Diagnostics Technology Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Noninvasive Cancer Diagnostics Technology Market Size by Country (2023-2028) & (US$ Million)
Table 43. Precision Therapeutics Company Detail
Table 44. Precision Therapeutics Business Overview
Table 45. Precision Therapeutics Noninvasive Cancer Diagnostics Technology Product
Table 46. Precision Therapeutics Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022) & (US$ Million)
Table 47. Precision Therapeutics Recent Development
Table 48. Affymetrix Inc. Company Detail
Table 49. Affymetrix Inc. Business Overview
Table 50. Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Product
Table 51. Affymetrix Inc. Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022) & (US$ Million)
Table 52. Affymetrix Inc. Recent Development
Table 53. Gen-Probe Incorporated Company Detail
Table 54. Gen-Probe Incorporated Business Overview
Table 55. Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Product
Table 56. Gen-Probe Incorporated Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022) & (US$ Million)
Table 57. Gen-Probe Incorporated Recent Development
Table 58. AVIVA Biosciences Corporation Company Detail
Table 59. AVIVA Biosciences Corporation Business Overview
Table 60. AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Product
Table 61. AVIVA Biosciences Corporation Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022) & (US$ Million)
Table 62. AVIVA Biosciences Corporation Recent Development
Table 63. A&G Pharmaceutical Company Detail
Table 64. A&G Pharmaceutical Business Overview
Table 65. A&G Pharmaceutical Noninvasive Cancer Diagnostics Technology Product
Table 66. A&G Pharmaceutical Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022) & (US$ Million)
Table 67. A&G Pharmaceutical Recent Development
Table 68. BIOVIEW Inc. Company Detail
Table 69. BIOVIEW Inc. Business Overview
Table 70. BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Product
Table 71. BIOVIEW Inc. Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022) & (US$ Million)
Table 72. BIOVIEW Inc. Recent Development
Table 73. Quest Diagnostics Incorporated Company Detail
Table 74. Quest Diagnostics Incorporated Business Overview
Table 75. Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Product
Table 76. Quest Diagnostics Incorporated Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022) & (US$ Million)
Table 77. Quest Diagnostics Incorporated Recent Development
Table 78. Digene Corporation Company Detail
Table 79. Digene Corporation Business Overview
Table 80. Digene Corporation Noninvasive Cancer Diagnostics Technology Product
Table 81. Digene Corporation Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022) & (US$ Million)
Table 82. Digene Corporation Recent Development
Table 83. Laboratory Corporation of America Holdings. Company Detail
Table 84. Laboratory Corporation of America Holdings. Business Overview
Table 85. Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Product
Table 86. Laboratory Corporation of America Holdings. Revenue in Noninvasive Cancer Diagnostics Technology Business (2017-2022) & (US$ Million)
Table 87. Laboratory Corporation of America Holdings. Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Noninvasive Cancer Diagnostics Technology Market Share by Technology: 2021 VS 2028
Figure 2. Immunoassays Features
Figure 3. Molecular Diagnostics Features
Figure 4. Clinical Chemistry Features
Figure 5. Others Features
Figure 6. Global Noninvasive Cancer Diagnostics Technology Market Share by Application in 2021 & 2028
Figure 7. Medical Device Manufacturing Company Case Studies
Figure 8. Oncology Laboratories Case Studies
Figure 9. Government and Private Research Institutions Case Studies
Figure 10. Academic Institutions and Pharmaceutical Companies Case Studies
Figure 11. Others Case Studies
Figure 12. Noninvasive Cancer Diagnostics Technology Report Years Considered
Figure 13. Global Noninvasive Cancer Diagnostics Technology Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Noninvasive Cancer Diagnostics Technology Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Noninvasive Cancer Diagnostics Technology Market Share by Region: 2021 VS 2028
Figure 16. Global Noninvasive Cancer Diagnostics Technology Market Share by Players in 2021
Figure 17. Global Top Noninvasive Cancer Diagnostics Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Cancer Diagnostics Technology as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Noninvasive Cancer Diagnostics Technology Revenue in 2021
Figure 19. North America Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. North America Noninvasive Cancer Diagnostics Technology Market Share by Country (2017-2028)
Figure 21. United States Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Noninvasive Cancer Diagnostics Technology Market Share by Country (2017-2028)
Figure 25. Germany Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Noninvasive Cancer Diagnostics Technology Market Share by Region (2017-2028)
Figure 33. China Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Japan Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. South Korea Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Southeast Asia Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. India Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Australia Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Noninvasive Cancer Diagnostics Technology Market Share by Country (2017-2028)
Figure 41. Mexico Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Brazil Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Noninvasive Cancer Diagnostics Technology Market Share by Country (2017-2028)
Figure 45. Turkey Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Saudi Arabia Noninvasive Cancer Diagnostics Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Precision Therapeutics Revenue Growth Rate in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
Figure 48. Affymetrix Inc. Revenue Growth Rate in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
Figure 49. Gen-Probe Incorporated Revenue Growth Rate in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
Figure 50. AVIVA Biosciences Corporation Revenue Growth Rate in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
Figure 51. A&G Pharmaceutical Revenue Growth Rate in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
Figure 52. BIOVIEW Inc. Revenue Growth Rate in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
Figure 53. Quest Diagnostics Incorporated Revenue Growth Rate in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
Figure 54. Digene Corporation Revenue Growth Rate in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
Figure 55. Laboratory Corporation of America Holdings. Revenue Growth Rate in Noninvasive Cancer Diagnostics Technology Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
